Preventing Relapse to Smoking Among Prisoners After Release (NCT04271371) | Clinical Trial Compass
CompletedNot Applicable
Preventing Relapse to Smoking Among Prisoners After Release
United Kingdom40 participantsStarted 2019-08-08
Plain-language summary
Prisoners experience huge health inequalities, and their exceptionally high smoking prevalence (five times the national average) contributes significantly to their high mortality. Since the introduction of smoke-free polices across Her Majesty's Prison and Probation Service (HMPPS) in England and Wales, prisoners are now obliged to abstain from smoking while held in prison. This represents a unique opportunity to promote lifelong cessation in this highly disadvantaged and marginalised group. However, evidence suggests most prisoners intend to resume smoking as soon as possible after release. A systematic review of prison smoke-free polices worldwide concluded that there was a need for new research to identify effective strategies to reduce relapse in these individuals.
Who can participate
Age range
18 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria 2. Release prisoner cohort
* All participants are aged 18 or over (no upper age limit)
* Are currently residing in one of the three study sites (HMPs Nottingham, Ranby and Sudbury)
* Male (women will not be held at any of the study sites)
* Have a provisional release date within the next 2 months.
* Are capable of understanding and consenting to the study.
* Remand and sentenced prisoners.
* Who report that they are a current smoker and/or a current smoker prior to entering prison (smoked up to 7 days before entering prison), and/or were in prison (and still on the same sentence) and a current smoker prior to the smoke-free prison policy.
3\. Reception prisoner cross-sectional
* All participants are aged 18 or over (no upper age limit)
* Are currently residing in the open prison study site (HMP Sudbury)
* Male (women will not be held at any of the study sites)
* Have been in the open prison more than two weeks but for less than 3 months.
* Have been transferred from a closed prison.
* Are capable of understanding and consenting to the study.
* Sentenced prisoners.
* Who report that they were a current smoker prior to entering prison (smoked up to 7 days before entering prison), and/or were in prison (and still on the same sentence) and a current smoker prior to the smoke-free prison policy.
Exclusion criteria 2. Release prisoner cohort
* Present a serious risk of harm to the researchers, highlighted in PNOMIS records or by a member of staff.
* Non-smo…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
To develop and pilot test the feasibility and acceptability of an intervention to help prevent prisoners relapse to smoking after release.